1
|
Leibowitz D, Yoshida Y, Jin Z, Mannina C, Homma S, Nakanishi K, Elkind MS, Rundek T, Di Tullio MR. Long term aortic arch plaque progression in older adults. ATHEROSCLEROSIS PLUS 2023; 52:18-22. [PMID: 37250431 PMCID: PMC10220301 DOI: 10.1016/j.athplu.2023.05.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/29/2023] [Revised: 05/05/2023] [Accepted: 05/19/2023] [Indexed: 05/31/2023]
Abstract
Background and aims The presence of aortic arch plaques (AAP) is significantly associated with increased cardiovascular morbidity and mortality. Few studies have examined the incidence of AAP progression and factors which may contribute to it using transthoracic echocardiography (TTE). The objective of this study was to utilize sequential imaging of the aortic arch using TTE to examine the rate of AAP progression and its risk factors in a cohort of older adults. Methods Participants enrolled in both the Cardiovascular Abnormalities and Brain Lesion study (years 2005-2010) and the Subclinical Atrial Fibrillation and Risk of Ischemic Stroke study (2014-2019) who underwent TTE with assessment of aortic arch plaques at both time points represent the study cohort. Results 300 participants were included in the study. Mean age was 67.8 ± 7.5 years at baseline, and 76.7 ± 6.8 years at follow-up; 197 (65.7%) were women. At baseline, 87 (29%) had no significant AAP, 182 (60.7%) had evidence of small AAP (2.0-3.9 mm) and 31 (10.3%) had evidence of large (≥4 mm) AAP. At the time of follow-up assessment, 157 (52.3%) of participants exhibited progression of AAP with 70 (23.3%) having mild progression and 87 (29%) having severe progression. There were no significant demographic or clinical predictors of AAP progression except baseline plaque thickness itself which was significantly lower in the group with AAP progression. Conclusions Our study demonstrates a high prevalence of AAP on TTE exam in a population-based cohort of older adults with a high incidence of AAP progression. TTE is a useful test for baseline and follow up imaging of AAP, even in subjects with no or little AAP at baseline.
Collapse
Affiliation(s)
- David Leibowitz
- Department of Medicine, New York, NY, USA
- Heart Institute, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
| | | | - Zhezhen Jin
- Department of Biostatistics, Columbia University, New York, NY, USA
| | | | | | - Koki Nakanishi
- Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan
| | - Mitchell S.V. Elkind
- Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
| | - Tatjana Rundek
- Department of Neurology, Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, FL, USA
- Department of Public Health Sciences, USA
- Clinical and Translational Science Institute, Miller School of Medicine, University of Miami, FL, USA
| | | |
Collapse
|
2
|
Evangelista A, Moral S, Ballesteros E, Castillo-Gandía A. Beyond the term penetrating aortic ulcer: A morphologic descriptor covering a constellation of entities with different prognoses. Prog Cardiovasc Dis 2020; 63:488-495. [PMID: 32497587 DOI: 10.1016/j.pcad.2020.05.006] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Abstract
Penetrating aortic ulcer (AU) is defined as localized disruption of the intimal layer of the aortic wall, resulting in a crater-like lesion outpouching from the vessel contour. AU is a generic term which encompasses a constellation of entities with different etiologies and prognoses and may be a complication of infective, inflammatory, traumatic, iatrogenic, atherosclerotic processes or intramural hematoma. One of the most challenging scenarios of AU for a differential diagnosis, but also for treatment implications, is when they are associated with acute aortic syndrome. Despite advances in the field of aortic disease, lack of consensus defining these lesions and the significant semantic confusion in the medical literature of the acronym PAU (for penetrating aortic ulcer but also for penetrating atherosclerotic ulcer) have given rise to controversy in guidelines and expert consensus, leading to the same treatment being recommended for entities with different etiology and prognosis. Moreover, in the medical literature, most diagnoses were mainly based on imaging techniques which identified AU regardless of clinical symptoms, surrounding imaging findings or dynamic morphologic changes. In this Review, we provide the latest insight into the differential diagnosis between AU, also called penetrating aortic ulcers, based on clinical context and the newest imaging characteristics to aid treatment decision-making.
Collapse
Affiliation(s)
- Arturo Evangelista
- Cardiology Department, Hospital General Universitari Vall d'Hebron, VHIR, CIBER-CV, Barcelona, Spain; Heart Institute, Quirónsalud-Teknon, Barcelona, Spain.
| | - Sergio Moral
- Cardiology Department, Hospital Universitari Doctor Josep Trueta, CIBER-CV, Girona, Spain
| | - Esther Ballesteros
- Radiology Department, Centro de atención primaria Pare Claret, Institut Català de la Salut, Barcelona, Spain
| | | |
Collapse
|
3
|
Izumi C, Miyake M, Amano M, Matsutani H, Hashiwada S, Kuwano K, Kuroda M, Nishimura S, Yoshikawa Y, Takahashi Y, Onishi N, Tamaki Y, Enomoto S, Tamura T, Kondo H, Kaitani K, Nakagawa Y. Risk Factors of Aortic Plaque Progression Evaluated by Long-Term Follow-Up Data With Transesophageal Echocardiography. Am J Cardiol 2017; 119:1872-1876. [PMID: 28377020 DOI: 10.1016/j.amjcard.2017.02.036] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/05/2017] [Revised: 02/22/2017] [Accepted: 02/22/2017] [Indexed: 11/19/2022]
Abstract
There are few longitudinal data regarding aortic plaque. This study aimed to examine chronological changes in aortic plaques with transesophageal echocardiography (TEE), and to clarify the risk factors of aortic plaque progression. Among 2,675 consecutive patients who underwent TEE, we retrospectively investigated 252 patients who underwent follow-up TEE with an interval >3 years. The thickness and morphology of aortic plaques were examined. Chronological changes in aortic plaques were investigated by comparing baseline and follow-up TEE. Clinical factors, laboratory data, and medications were evaluated. Among 252 study patients, the grade of aortic plaques was unchanged in 213 (group U), but progression was observed in 32 (group P) and regression in 7 patients (group R). Patients in group P were older; they had a higher prevalence of coronary artery disease, hypertension, smoking habit, and moderate or severe plaque at baseline TEE; more patients were using statins and no warfarin; and they had higher creatinine levels than those in group U. In multivariate analysis, moderate or severe plaques at baseline TEE were the strongest predictor of plaque progression. Among 50 patients who showed moderate or severe plaque at baseline TEE, smoking habit and no anticoagulation therapy were predictors of plaque progression. In conclusion, aortic plaques should be followed up using TEE in patients with moderate or severe plaque at baseline TEE.
Collapse
Affiliation(s)
- Chisato Izumi
- Department of Cardiology, Tenri Hospital, Tenri, Japan.
| | - Makoto Miyake
- Department of Cardiology, Tenri Hospital, Tenri, Japan
| | - Masashi Amano
- Department of Cardiology, Tenri Hospital, Tenri, Japan
| | | | | | - Kazuyo Kuwano
- Department of Clinical Pathology, Tenri Hospital, Tenri, Japan
| | - Maiko Kuroda
- Department of Cardiology, Tenri Hospital, Tenri, Japan
| | | | | | | | - Naoaki Onishi
- Department of Cardiology, Tenri Hospital, Tenri, Japan
| | - Yodo Tamaki
- Department of Cardiology, Tenri Hospital, Tenri, Japan
| | | | | | | | | | | |
Collapse
|
4
|
Sengupta A, Ghosh M. Reduction of cardiac and aortic cholesterol in hypercholesterolemic rats fed esters of phytosterol and omega-3 fatty acids. JOURNAL OF FOOD SCIENCE AND TECHNOLOGY 2015; 52:2741-50. [PMID: 25892771 PMCID: PMC4397298 DOI: 10.1007/s13197-014-1346-2] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Revised: 03/14/2014] [Accepted: 03/26/2014] [Indexed: 01/24/2023]
Abstract
Sterol esters are currently gaining importance because of their recent recognition and application in the food and nutraceutical industries. Phytosterol esters have an advantage over phytosterols, naturally occurring antioxidants, with better fat solubility and compatibility. Antioxidants and hypocholesterolemic agents are known to reduce hypercholesterolemic atherosclerosis. The objective of the study was to determine the effects of different sterol esters on cardiac and aortic lipid profile and oxidative stress parameters and on the development of atherosclerosis in rats fed a high-cholesterol diet. Thirty six rats were divided into six groups: control group, hypercholesterolemic group and four experimental groups fed with EPA-DHA rich sitosterol ester in two different doses, 0.25 g/kg body wt/day and 0.5 g/kg body wt/day, and ALA rich sitosterol ester in two different doses, 0.25 g/kg body wt/day and 0.5 g/kg body wt/day. The sterol esters were gavaged to the rats once daily for 32 days. The cardiac and aortic total cholesterol, non-HDL cholesterol and triglyceride level which were elevated in hypercholesterolemia were significantly lowered by both the doses of sterol esters. Antioxidant enzyme activities were significantly decreased and peroxidation product, malondialdehyde was increased in hypercholesterolemia. But administration of both the sterol esters was able to increase enzyme activities and decrease MDA level in the tissues. Histological study of cardiac tissues showed fatty changes in hypercholesterolemic group which was reduced by treatment with sterol esters. The higher doses of sterol-ester caused better effects against hypercholesterolemic atherosclerosis.
Collapse
Affiliation(s)
- Avery Sengupta
- Department of Chemical Technology, University College of Science & Technology, University of Calcutta, 92, A.P.C. Road, Kolkata, 700009 India
| | - Mahua Ghosh
- Department of Chemical Technology, University College of Science & Technology, University of Calcutta, 92, A.P.C. Road, Kolkata, 700009 India
| |
Collapse
|
5
|
Kaneko K, Saito H, Takahashi T, Kiribayashi N, Omi K, Sasaki T, Niizeki T, Sugawara S, Akasaka M, Kubota I. Rosuvastatin improves plaque morphology in cerebral embolism patients with normal low-density lipoprotein and severe aortic arch plaque. J Stroke Cerebrovasc Dis 2014; 23:1682-9. [PMID: 24739590 DOI: 10.1016/j.jstrokecerebrovasdis.2014.01.018] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2013] [Revised: 01/10/2014] [Accepted: 01/16/2014] [Indexed: 10/25/2022] Open
Abstract
The effect of rosuvastatin was investigated on complicated aortic arch plaque (CAP) morphology and lipid profiles in acute cerebral embolism (CE) patients with normal low-density lipoprotein-cholesterol (LDL-c) levels. Transesophageal echocardiography (TEE) studies were performed in 56 consecutive CE patients with LDL-c less than 140 mg/dL who were not taking lipid-lowering agents at baseline. CAP observed by TEE was defined as the presence of greater than 4-mm diameter, ulcerated, or mobile aortic plaque. Patients were divided into those with CAP versus without CAP (group A, n=24, age 69±8 years) and without CAP (group B, n=32, age 62±10 years). Of the 24 group A patients, 18 received 5 mg/d of rosuvastatin for 6 months and had follow-up TEE studies. In Group A, the baseline values of high-density lipoprotein-cholesterol (HDL-c) and apolipoprotein A-1 (ApoA-1) were significantly lower than in Group B (44±15 versus 55±15 mg/dL, P=.0059; 103±19 versus 137±25 mg/dL, P=.0006, respectively) and age and serum high-sensitivity C-reactive protein concentration were significantly higher (69±8 vs. 62±10 years, P=.0080; 2.34±3.05 vs. 0.67±1.00 mg/dL, P=.0054, respectively). By multivariate logistic regression analysis, ApoA-1 was shown to be an independent predictor of CAP (odds ratio=.894, 95% confidence intervals .800-.996, P=.0483). In the 18 group A patients receiving rosuvastatin for 6 months, aortic arch plaque diameter and serum LDL-c were significantly decreased (5.8±2.2 to 5.1±2.1 mm, P=.0377; 110±23 to 81±23 mg/dL, P=.0008, respectively), whereas serum HDL-c and ApoA-1 concentrations were significantly increased (42±8 to 52±9 mg/dL, P=.0002; 109±22 to 135±15 mg/dL, P=.0002, respectively). Plaques were morphologically improved in 11 patients, unchanged in 6, and worsened in 1. These data suggest that rosuvastatin improves plaque morphology concomitant with improving lipid profiles in CE patients with normal LDL-c levels.
Collapse
Affiliation(s)
- Kazuyoshi Kaneko
- Department of Cardiology, Yamagata Prefectural and Sakata Municipal Hospital Organization, Nihonkai General Hospital, Sakata, Japan.
| | - Hiroki Saito
- Department of Cardiology, Yamagata Prefectural and Sakata Municipal Hospital Organization, Nihonkai General Hospital, Sakata, Japan
| | - Tetsuya Takahashi
- Department of Cardiology, Yamagata Prefectural and Sakata Municipal Hospital Organization, Nihonkai General Hospital, Sakata, Japan
| | - Nobuyuki Kiribayashi
- Department of Cardiology, Yamagata Prefectural and Sakata Municipal Hospital Organization, Nihonkai General Hospital, Sakata, Japan
| | - Koki Omi
- Department of Cardiology, Yamagata Prefectural and Sakata Municipal Hospital Organization, Nihonkai General Hospital, Sakata, Japan
| | - Toshiki Sasaki
- Department of Cardiology, Yamagata Prefectural and Sakata Municipal Hospital Organization, Nihonkai General Hospital, Sakata, Japan
| | - Takeshi Niizeki
- Department of Cardiology, Yamagata Prefectural and Sakata Municipal Hospital Organization, Nihonkai General Hospital, Sakata, Japan
| | - Shigeo Sugawara
- Department of Cardiology, Yamagata Prefectural and Sakata Municipal Hospital Organization, Nihonkai General Hospital, Sakata, Japan
| | - Masahiro Akasaka
- Department of Neurosurgery, Yamagata Prefectural and Sakata Municipal Hospital Organization, Nihonkai General Hospital, Sakata, Japan
| | - Isao Kubota
- Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan
| |
Collapse
|
6
|
Kamberi LS, Bedri Bakalli A, Muhamet Budima N, Rashit Gorani D, Karabulut AM, Talat Pallaska K. Pleiotropic and Lipid-lowering Effects of Statins in Hypertension. Mater Sociomed 2012; 24:84-6. [PMID: 23678313 PMCID: PMC3633393 DOI: 10.5455/msm.2012.24.84-86] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2012] [Accepted: 04/25/2012] [Indexed: 11/22/2022] Open
Abstract
BACKGROUND Data on the lowering effects of statins in hypertensive patients have been mixed and highly controversial. Some studies shows reductions effects of statins in blood pressure, whereas others do not. The evidence in the literature on the effects of statins on blood pressure raises the possibility that statins may directly lower blood pressure in addition to reduce cholesterol levels-pleiotropic effects of statins. AIM OF THE STUDY The role of statins as additional treatment in patients with severe hypertension and advanced aortic atherosclerotic plaques. Methods. We enrolled 62 patients. Study has been approved by Committee of Ethics and patients signed a Term of Free Informed Consent. All patients were studied with transoesophageal echocardiography at baseline and 12 months after enrolment. Inclusion criteria were severe hypertension and presence of aortic atherosclerotic plaques. Patients have been divided into two groups; group A (treated with antihypertenives and statins) and group B (treated, just with antihypertensives). RESULTS Twenty patients, of totally 38, from group A (20/38 or 52.6%) had significantly plaque reduction. One patient of totally 24 (1/24 or 4.1% ) from group B had significantly atherosclerotic plaque reduction. Difference of plaques reduction between two groups was highly significant. Regarding blood pressure levels, statins users had significantly reduction on systolic and diastolic blood pressure compared to statins nonusers. CONCLUSION Hypertensive patients with presence of AA plaques treated with antihypertensives and statins have more BP reduction compared will hypertensive patients treated with antihypertensives alone.
Collapse
|
7
|
De Castro S, Papetti F, Di Angelantonio E, Razmovska B, Truscelli G, Tuderti U, Puca E, Correnti A, Fiorelli M, Prencipe M, Toni D. Feasibility and clinical utility of transesophageal echocardiography in the acute phase of cerebral ischemia. Am J Cardiol 2010; 106:1339-44. [PMID: 21029835 DOI: 10.1016/j.amjcard.2010.06.066] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/13/2010] [Revised: 06/16/2010] [Accepted: 06/16/2010] [Indexed: 11/16/2022]
Abstract
We evaluated the feasibility and clinical utility of transesophageal echocardiography (TEE) in the early management of ischemic stroke. TEE was performed in consecutive patients with acute cerebral ischemia within 48 hours of symptoms onset. The data were analyzed by age (<55 vs ≥55 years), and the baseline stroke etiology was classified (determined vs undetermined). TEE was feasible in 660 (61%) of 1,080 patients. Left atrial abnormalities and complicated aortic plaques prevailed in older patients (p <0.05), irrespective of the stroke etiology. A patent foramen ovale prevailed in younger patients (p <0.05) but even in older patients was present in 13% of the determined and 31% of the undetermined stroke subgroups. Overall, high-risk and potentially high-risk cardioembolic sources were detected in 47% of the patients, and stroke etiology was consequently reviewed: 40% of the baseline undetermined strokes were reclassified as cardioembolic, and 29% of lacunar, 42% of large artery, and 30% of other determined-cause strokes were reclassified as concurrent etiology. Subsequently, according to the current guidelines, 12% of patients were reassigned from antiplatelet to anticoagulant therapy and 17% of patients were treated with high-dose statins; overall, secondary prevention treatment was modified in 26% of patients. In conclusion, TEE was feasible in about 2/3 of the patients investigated within 48 hours of the index event, contributed to stroke classification in 1/3 of cases, and guided secondary prevention therapy in 1/4 of patients. Therefore, TEE is useful for defining patients' risk profile for stroke recurrence.
Collapse
Affiliation(s)
- Stefano De Castro
- Heart and Great Vessels "A. Reale" Department, "Sapienza" University of Rome, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Kohsaka S, Jin Z, Rundek T, Homma S, Sacco RL, Di Tullio MR. Relationship between serum lipid values and atherosclerotic burden in the proximal thoracic aorta. Int J Stroke 2010; 5:257-63. [PMID: 20636707 DOI: 10.1111/j.1747-4949.2010.00437.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
BACKGROUND We conducted a cross-sectional analysis in a population-based cohort to compare the strength of the associations among various lipid parameters and the presence of atherosclerotic plaque in the proximal thoracic aorta. METHODS As part of Aortic Plaques and Risk of Ischemic Stroke (APRIS) study, 464 subjects were studied (mean age 69.1 +/- 9.0, 251 males and 213 females), including 255 patients with first ischaemic stroke and 209 stroke-free controls. Presence and thickness of atherosclerotic plaque were assessed by transoesophageal echocardiography. Measured lipid parameters included total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein, and non-high-density lipoprotein cholesterol, lipoprotein (a), apolipoprotein (Apo) B and A-I levels with their ratio. RESULTS Overall, atherosclerotic plaque was detected in 326 subjects (70.4%) and 37.6% of these subjects (n=174) had atherosclerotic plaque > or =4 mm. After adjusting for other significant predictors of atherosclerosis, high-density lipoprotein cholesterol level and Apo B/A-I ratio emerged as the strongest predictors of any atherosclerotic plaque (P<0.001 and P=0.004, respectively), followed by individual Apo B (P=0.015) and A-I (P=0.016) levels, triglycerides (P=0.027) and non-high-density lipoprotein cholesterol level (P=0.021). Total and low-density lipoprotein cholesterol levels were not significant predictors for any atherosclerotic plaque (P=0.273 and P=0.081, respectively). High-density lipoprotein cholesterol level (P=0.008) and Apo A-I (P=0.006) were also significant predictors of atherosclerotic plaque > or =4 mm. Similar trends were observed after exclusion of subjects on cholesterol lowering drugs. CONCLUSION High-density lipoprotein cholesterol level and Apo B/A-I ratio, but not total or low-density lipoprotein cholesterol levels, were strongly associated with degree of proximal aortic atherosclerosis.
Collapse
Affiliation(s)
- Shun Kohsaka
- Department of Medicine, Division of Cardiology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
| | | | | | | | | | | |
Collapse
|